Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropenia.

IF 7.9 1区医学 Q1 HEMATOLOGY Haematologica Pub Date : 2024-10-17 DOI:10.3324/haematol.2024.286062

Florent Puisset,Emmanuel Raffoux,Lionel Ades,Tony Huynh,Raphaël Itzykson,Didier Bouscary,Loréa Aguinana,Florence Rabian,Marie Sebert,Anne Vekhoff,Eolia Brissot,Mohamad Mohty,Agnes Bonnin,Alexis Genthon,Jeremie Zerbit,Lise Willems,Justine Decrocq,Adrien Contejean,Etienne Lengline,Samia Mourah,Lauriane Goldwirt

引用次数: 0

Abstract

Not available.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

急性髓性白血病患者在实际生活中暴露于 Venetoclax 的毒性：高暴露对延迟性中性粒细胞减少症的影响。

不详。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.

期刊最新文献

Outcomes of real-world complete responders after fixed-duration glofitamab in relapsed/refractory large B-cell lymphoma. Preemptive hematopoietic stem cell transplantation in RUNX1 familial platelet disorder: a shared decision-making framework. Pharmacological blockade of rho kinase enhances venetoclax responses in translational models of acute myeloid leukemia. Hypomethylating agents plus venetoclax versus intensive chemotherapy prior to transplant in high-risk acute myeloid leukemia. CAR-T therapy for relapsed/refractory large B-cell lymphoma in people living with HIV: efficacy, toxicity and treatment considerations.